Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26FJ3U6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,484
Award facts
- Contract value 100% obligated
- $11,484.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with a ceiling value of $11,484.29. This firm fixed-price delivery order, awarded on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order enables the DLA to procure critical pharmaceutical supplies through an established relationship with one of the federal government's primary pharmaceutical distributors.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts. The company's extensive portfolio with the DLA encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting military readiness and veteran healthcare initiatives worldwide.
Quick answers
Who was awarded contract SPE2DR26FJ3U6?
SPE2DR26FJ3U6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FJ3U6 worth?
The government has obligated $11,484 on SPE2DR26FJ3U6.
Is contract SPE2DR26FJ3U6 an order under another contract?
Yes. SPE2DR26FJ3U6 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ3U6 competed?
The extent of competition for SPE2DR26FJ3U6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award